SPONSORED POST*
As Bitcoin (BTC) approaches Q4, a period when it historically gains momentum, a popular analyst says Pepe (PEPE), Arweave (AR), and Injective (INJ) are three altcoins worth watching. Nevertheless, many other experts say ETFSwap (ETFS) provides superior profit-making opportunities.
ETFSwap (ETFS) Provides The Best Long-Term Investment Opportunity
ETFSwap (ETFS) is the native token of the ETFSwap platform. The token has been praised by analysts and other experts in the crypto community for its excellent profit potential. ETFSwap’s (ETFS) potency has been linked to its extensive utility on its innovative, future-proof ETF trading platform. Furthermore, its incredible presale success reinforces ETFSwap’s (ETFS) favorable projection.
The ETFSwap platform is the prime destination for trading and investing in highly liquid tokenized exchange-traded funds (ETFs). The ETFSwap platform’s innovative solution to offer these assets attracts the crypto community and institutional investment circles.
ETFSwap (ETFS) allows traders and investors to enjoy huge discounts on trading fees on the ETFSwap platform, among other incentives. Holding the token also entitles them to receive monthly airdrops from the dedicated rewards pool, which consists of the sell tax deducted from trading fees. Additionally, staking ETFswap (ETFS) allows token holders to earn passive income with an 87% APR yield potential.
The combination of a futuristic platform and a promising token makes ETFSwap (ETFS) a force to reckon with in the financial space. ETFSwap (ETFS) started the third phase of its ICO three days ago and has already raised over $1.31 million. Thanks to these factors, ETFSwap (ETFS) is projected to rally up to $1.8 at launch, representing a huge 4,680% rally for the altcoin.
Analyst Says Watch These Altcoins As Bitcoin (BTC) Nears Q4 – PEPE, Arweave (AR), And Injective (INJ)
Renowned crypto analyst Crypto Banter explained in a recent episode of his YouTube show, The Sniper Trading Show, why he believes Bitcoin’s (BTC) price will soon gain momentum. He also highlighted PEPE, Arweave (AR), and Injective (INJ) as altcoins investors should watch for profits.
Bitcoin (BTC) is trading at $58,125, and Crypto Banter believes the premier cryptocurrency is headed for a surge as we enter Q4 2024. Historically, Q4 has been a favorable period for Bitcoin (BTC) as Bitcoin (BTC) prices usually rise between October and December. We could see Bitcoin (BTC) hit $65,000 before year’s end.
Discussing Pepe (PEPE), Crypto Banter said it is an excellent long-term investment, albeit with some short-term volatility. He cited PEPE’s current price as an excellent buying opportunity. Alternatively, investors who hesitate can wait till Pepe (PEPE) declines 3% more before buying and should be looking forward to a 26-30% gain from their Pepe (PEPE) investments.
He next discussed Arweave (AR), which is currently dipping. However, the analyst believes it is a good time to buy the altcoin as a long-term investment. Crypto Banter speculated that Arweave (AR) may decline to $17, but upcoming positive developments in the Arweave (AR) ecosystem should see the altcoin soaring soon. According to CoinMarketCap data, Arweave (AR) is trading at $19.65.
Finally, Crypto Banter discussed Injective (INJ), which is trading at $19.03. Injective (INJ) has had an impressive seven-day run but is only 1.77% more than last month’s price. Nevertheless, he believes the release of the Consumer Price Index (CPI) data, known to create market volatility, will drive Injective’s (INJ) price upward.
Conclusion
As Bitcoin (BTC) heads for its “most wonderful time of the year,” altcoins should enjoy a general bullishness. Therefore, investors can gain substantially from altcoins Pepe (PEPE), Arweave (AR), and Injective (INJ), as Crypto Banter says.
Nevertheless, ETFSwap’s potential to surge massively surpasses these other altcoins. Smart investors are joining the presale to position themselves for huge profits. The 50% bonus promo allows them to accumulate more tokens and multiply their potential rewards.
For more information about the ETFS Presale:
*This article was paid for. Cryptonomist did not write the article or test the platform.